Literature DB >> 3524724

A double-blind gluten-free/gluten-load controlled trial in a secure ward population.

D N Vlissides, A Venulet, F A Jenner.   

Abstract

A double-blind control trial of gluten-free versus a gluten-containing diet was carried out in a ward of maximum security hospital: 24 patients were studied for 14 weeks. Most suffered from psychotic disorders, particularly schizophrenia. Various dimensions of behaviour were rated on the Psychotic In-Patient profile (PIP) at different stages. There were beneficial changes in the whole group of patients between pre-trial and gluten-free period in five dimensions of the PIP, maintained during the gluten challenge period; these changes could be attributed to the attention the patients received. Two patients improved during the gluten-free period and relapsed when the gluten diet was reintroduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524724     DOI: 10.1192/bjp.148.4.447

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

Authors:  Deanna L. Kelly; Haley K. Demyanovich; Katrina M. Rodriguez; Daniela Ciháková; Monica V. Talor; Robert P. McMahon; Charles M. Richardson; Gopal Vyas; Heather A. Adams; Sharon M. August; Alessio Fasano; Nicola G. Cascella; Stephanie M. Feldman; Fang Liu; MacKenzie A. Sayer; Megan M. Powell; Heidi J. Wehring; Robert W. Buchanan; James M. Gold; William T. Carpenter; William W. Eaton
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

Review 2.  Gluten- and casein-free diets for autistic spectrum disorder.

Authors:  C Millward; M Ferriter; S Calver; G Connell-Jones
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 3.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

4.  Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review.

Authors:  Anastasia Levinta; Ilya Mukovozov; Christopher Tsoutsoulas
Journal:  Adv Nutr       Date:  2018-11-01       Impact factor: 8.701

Review 5.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

6.  A study of circulating gliadin antibodies in schizophrenia among a Chinese population.

Authors:  Shun-Zi Jin; Ning Wu; Qi Xu; Xuan Zhang; Gui-Zhi Ju; Matthew H Law; Jun Wei
Journal:  Schizophr Bull       Date:  2010-09-30       Impact factor: 9.306

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

Review 8.  Extraintestinal manifestations of coeliac disease.

Authors:  Daniel A Leffler; Peter H R Green; Alessio Fasano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

9.  Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients.

Authors:  Benjamin Niland; Brooks D Cash
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

10.  Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature.

Authors:  Bryan D Kraft; Eric C Westman
Journal:  Nutr Metab (Lond)       Date:  2009-02-26       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.